In contrast to what happens in other cellular models, in which soluble Notch ligands have an antagonistic effect [27–30], in CLL we showed that both soluble and immobilized DLL4 had an activating effect in Notch1 signaling. Here, DLL4 is linked to B-cell chronic lymphocytic leukemia.